MLL
Münchner Leukämielabor

Diagnostics

We are the interdisciplinary experts

Our optimized diagnoses based on an extensive spectrum of methods help to extend life expectancy with improved quality of life.

 

Methods

The foundation for a specific therapy

Expertise, focus topics, state-of-the-art technology and tireless research – combined with our unwavering commitment to progress – guarantee optimized and individual diagnosis.

To the methods

Facts

  • 774902
    774902

    Samples received since 2005

  • 573
    573

    Publications

  • 206
    206

    Staff members

MLL Magazine

Stay up to date

Here you will find all MLL News as well as scientific contributions to leukemia diagnostics and research.

to the MLL Magazine

Current Articles

  • Prof. Dr. med. Dr. phil. Torsten Haferlach
    from 08.06.2020
    MLL News
    Leukemia diagnostics during the pandemic

    In the past few months, we have all been confronted with an entirely new situation. Our patients belong to the high-risk group by definition. Hospitals, outpatient clinics, and medical practices have had to be restructured and reorganize their priorities. Workflows had to be re-examined with regard to factual and time-related aspects with hygiene in mind. The goal has been to ensure continued care for patients, while at the same time protecting the employees trained for that very purpose.

    Post review
    Read article
  • Dr. med. Christian Pohlkamp
    from 08.06.2020
    Diagnostics
    Identifying resistance mutations in targeted therapies

    Over the past few years, the use of targeted therapies has proven effective for various forms of hematological neoplasia, and increasingly become routine. The rational molecular design of such active substances allows for the targeted blocking of intracellular signal chains in malignant cells, resulting e.g. in cell cycle arrest or ideally apoptosis. Unfortunately, resistance occurs even against such tailored therapies.

    Post review
    Read article

Events

Newsletter registration

Sign up for our MLL News and receive information on latest findings in leukemia diagnostics and research. Newsletter only available in German.

Join us!

»The visionary spirit of the management board inevitably spreads to us, the employees, as well.«

Jonas Reiter,
Head of the HR Department